Peter Pitts, a former associate commissioner of the FDA, joins "CUOMO" to discuss the resignation of Dr. Richard Pazdur, the FDA's drug chief, after less than a month on the job: “Rick was promised ...

So much for stability at the U.S. FDA. Three weeks after accepting the position as director of the FDA’s CDER, Richard Pazdur has informed the agency of his intention to retire at the end of the year.

After less than a month in his new role as head of the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), top drug regulator Richard Padzur has chosen to retire ...

Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug Administration lead drug regulator Richard Pazdur will resign, despite being only weeks ...

Current and former workers caution administration’s ‘politicization of science’ will negatively affect Americans ...

The U.S. Food and Drug Administration is often described as the most influential scientific regulator in the world. Its decisions shape global drug development, investment, and patient access. But in ...

The Trump administration's elevation of a vaccine skeptic to lead a high-profile office within the Food and Drug Administration is raising alarm among multiple senior FDA officials, who told CBS News ...

Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at least 10 children," 12 former FDA commissioners released an extraordinary ...

Former FDA commissioners warn of a threat to evidence-based vaccine policy and public health at the FDA. Concerns raised over new oversight policy.

Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from 12 former commissioners of the agency. The proposed changes, as laid out ...